[Postoperative morbidity and in-hospital mortality of gastrectomy due to gastric adenocarcinoma: a report of 50 years].

Objective: Determine the postoperative morbidity and in-hospital mortality of gastrectomy due to gastric cancer.

Method: The study involved the review of the clinical records of all patients with histologically confirmed diagnostic of gastric adenocarcinoma, which underwent a gastrectomy at the Peruvian Institute of Neoplastic Diseases between January 1950 and December 1999. During that period, 2,033 gastrectomies were performed, 503 of which were total gastrectomies and 1,447 were distal subtotal gastrectomies.

[OPERABILITY AND RESECTABILITY OF GASTRIC CANCER:ANALYSIS OF 2280 CASES IN 15 YEARS].

OBJECTIVES: To determine which are the operability and resectability tendencies of gastric cancer in Peru.BACKGROUND: In Peru, gastric cancer is the first cause of death in men and the third one in women. Most of the patients with gastric cancer receive treatment al the Instituto Nacional de Enfermedades Neoplásicas of Lima (INEN).

Gastric lymphomas: chemotherapy as a primary treatment.

Twenty-one of 65 patients with gastric lymphoma have been treated with combination chemotherapy; 17 patients had chemotherapy as primary treatment, and 4 had it for residual disease after incomplete surgical resection. Three of these patients were in stage III and 18 were in stage IV of the disease, according to the TNM Staging Classification. CHOP-Bleo or CHOP combination was given to 17 patients, and the COPP-Bleo regimen to three; the last one was treated with COP.

[Combined chemotherapy with the FEM protocol in advanced gastric cancer].

Thirty one patients with diagnosis of Gastric Cancer were admitted in this study. Median age was 71 years (range 24-82). Twenty two were male.